Showing results (931-940 of 973) with videos related to

Sort By:
Pageof 98
Journal of the American College of Cardiology|May 30, 2020
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent RestenosisDaniele Giacoppo, Fernando Alfonso, Bo Xu, et al.
AIDS (London, England)|April 15, 1999
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study GroupN G Pakker, E D Kroon, M T Roos, et al.
Circulation. Cardiovascular Interventions|November 18, 2017
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-AnalysisDhaval Kolte, Partha Sardar, Sahil Khera, et al.
International Journal of Cardiology|November 5, 2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary interventionMichela Faggioni, Usman Baber, Jaya Chandrasekhar, et al.
Journal of Cardiac Failure|November 13, 2025
Prognostic Value and Reproducibility of Simplified Noninvasive Pulmonary Artery Pressure-Flow Relationships in Exercise EchocardiographyYouri Bekhuis, Mauricio Milani, Maarten Falter, et al.
Journal of the American College of Cardiology|April 6, 2026
Masters Athletes With Abnormal Cardiovascular Findings: A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the American College of CardiologyThijs M H Eijsvogels, Jonathan H Kim, Vincent L Aengevaeren, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 27, 2026
Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trialBahram Yosofi, Eva C I Woelders, Denise A M Peeters, et al.
JACC. Cardiovascular Interventions|May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS RegistryLauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
European Heart Journal|June 25, 2025
Atrial fibrillation in former world-class rowers: role of environmental and genetic factorsM Darragh Flannery, Rodrigo Canovas, Kristel Janssens, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 3, 2023
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA studyNiels M R van der Sangen, Bimmer E P M Claessen, I Tarik Küçük, et al.
Pageof 98